E-Therapeutics axes MRSA drug - E-Therapeutics axes MRSA drug Drug discovery group reports a widening of first-half losses and decides to stop research into ETX1153a to focus on cancer treatment Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.